Treatment and harm reduction approaches for opioid use disorder have failed to effectively meet the needs of people of color, experts say.
Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for opioid use disorder.
Despite efforts to combat the opioid epidemic over the past decades, the data shows that death rates have not significantly improved — calling for a paradigm shift in how care is delivered.
Infectious disease physician Josh Barocas will use NIDA grant to create a novel surveillance network for people who use drugs, emphasizing community engagement.
The first multi-site study of the ESC model suggests a nonpharmacologic care model focused on maternal engagement is a safe option for widespread use.